Subtopic Deep Dive
Dermatophyte Antifungal Susceptibility
Research Guide
What is Dermatophyte Antifungal Susceptibility?
Dermatophyte Antifungal Susceptibility examines in vitro and in vivo resistance patterns of dermatophytes causing nail onychomycosis to drugs like terbinafine and azoles.
Studies focus on rising resistance in species like Trichophyton causing recalcitrant infections. Key work documents India-wide terbinafine resistance in dermatophytes (Ebert et al., 2020, 237 citations). Surveillance guides treatment amid increasing prevalence (Thomas et al., 2010, 309 citations).
Why It Matters
Rising terbinafine resistance in dermatophytes leads to treatment failures in onychomycosis, affecting millions globally (Thomas et al., 2010). Ebert et al. (2020) report high resistance prevalence in India, necessitating surveillance and new therapies. Ameen et al. (2014) guidelines highlight evidence-based management challenges due to resistance patterns. Roemer and Krysan (2014) emphasize unmet needs in antifungal development for such infections.
Key Research Challenges
Terbinafine Resistance Surge
Multicenter studies show alarming terbinafine resistance in Trichophyton species across India (Ebert et al., 2020). This reduces oral therapy efficacy for onychomycosis. Standardized testing protocols are needed for surveillance.
Limited Antifungal Pipeline
Few new drugs address dermatophyte resistance despite rising cases (Roemer and Krysan, 2014). Existing azoles face cross-resistance issues (Loeffler and Stevens, 2003). Development lags behind resistance evolution.
Inconsistent Susceptibility Testing
Variability in in vitro methods complicates resistance monitoring (Ameen et al., 2014). Clinical correlation with lab results remains poor. Guidelines call for standardized approaches.
Essential Papers
Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Terry Roemer, Damian J. Krysan · 2014 · Cold Spring Harbor Perspectives in Medicine · 566 citations
Invasive, life-threatening fungal infections are an important cause of morbidity and mortality, particularly for patients with compromised immune function. The number of therapeutic options for the...
Malassezia ecology, pathophysiology, and treatment
Bart Theelen, Claudia Cafarchia, Georgios Gaitanis et al. · 2017 · Medical Mycology · 320 citations
Malassezia are lipid dependent basidiomycetous yeasts that inhabit the skin and mucosa of humans and other warm-blooded animals, and are a major component of the skin microbiome. They occur as skin...
REVIEW ARTICLE: Toenail onychomycosis: an important global disease burden
Jackson Thomas, Glenn A. Jacobson, Christian Narkowicz et al. · 2010 · Journal of Clinical Pharmacy and Therapeutics · 309 citations
Onychomycosis is a fungal infection of the nail plate or nail bed. It does not usually cure itself and it can trigger more infectious lesions in other parts of the body. The reported prevalence of ...
Tinea Capitis: Current Status
Roderick J. Hay · 2016 · Mycopathologia · 263 citations
British Association of Dermatologists' guidelines for the management of onychomycosis 2014
Mahreen Ameen, John T. Lear, Vishal Madan et al. · 2014 · British Journal of Dermatology · 238 citations
The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of onychomycosis. The document aims to (i) offer an appraisal of all relevant lite...
Alarming India‐wide phenomenon of antifungal resistance in dermatophytes: A multicentre study
Andreas Ebert, Michel Monod, Karine Salamin et al. · 2020 · Mycoses · 237 citations
Abstract Background An alarming increase in recalcitrant dermatophytosis has been witnessed in India over the past decade. Drug resistance may play a major role in this scenario. Objectives The aim...
Antifungal Drug Resistance
Claudia Loeffler, David A. Stevens · 2003 · Clinical Infectious Diseases · 226 citations
The increasing incidence of invasive fungal infections is the result of many factors, including an increasing number of patients with severe immunosuppression. Although new drugs have been introduc...
Reading Guide
Foundational Papers
Start with Thomas et al. (2010) for onychomycosis epidemiology, then Ameen et al. (2014) guidelines, and Loeffler and Stevens (2003) for resistance basics.
Recent Advances
Ebert et al. (2020) on India-wide resistance; Roemer and Krysan (2014) on antifungal development needs.
Core Methods
Broth microdilution for MICs (Ameen et al., 2014); surveillance of clinical isolates (Ebert et al., 2020).
How PapersFlow Helps You Research Dermatophyte Antifungal Susceptibility
Discover & Search
Research Agent uses searchPapers and exaSearch to find Ebert et al. (2020) on India-wide dermatophyte resistance, then citationGraph reveals connections to Ameen et al. (2014) guidelines and Thomas et al. (2010) on onychomycosis burden.
Analyze & Verify
Analysis Agent applies readPaperContent to extract MIC data from Ebert et al. (2020), verifies resistance stats with verifyResponse (CoVe), and runs PythonAnalysis for meta-analysis of susceptibility trends across papers using GRADE for evidence grading.
Synthesize & Write
Synthesis Agent detects gaps in terbinafine alternatives via gap detection, then Writing Agent uses latexEditText, latexSyncCitations for Ebert et al. (2020), and latexCompile to produce reports with exportMermaid diagrams of resistance mechanisms.
Use Cases
"Analyze terbinafine MIC distributions from recent dermatophyte studies"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas for MIC stats, matplotlib histograms) → CSV export of resistance trends.
"Draft guidelines update on onychomycosis management with resistance data"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Ameen et al. 2014) → latexCompile → PDF with citations.
"Find code for dermatophyte susceptibility modeling"
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for MIC simulation.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ papers on dermatophyte resistance: searchPapers → citationGraph → DeepScan for 7-step verification → structured report with GRADE scores. Theorizer generates hypotheses on resistance mechanisms from Ebert et al. (2020) and Roemer and Krysan (2014). DeepScan analyzes susceptibility data checkpoints with runPythonAnalysis.
Frequently Asked Questions
What is Dermatophyte Antifungal Susceptibility?
It studies resistance of nail-infecting dermatophytes to antifungals like terbinafine via in vitro MIC testing.
What methods test dermatophyte susceptibility?
Standard broth microdilution measures MICs for terbinafine and azoles (Ameen et al., 2014). Clinical isolates guide in vivo correlation.
What are key papers?
Ebert et al. (2020, 237 citations) on India resistance; Ameen et al. (2014, 238 citations) on onychomycosis guidelines; Thomas et al. (2010, 309 citations) on disease burden.
What open problems exist?
Standardized global surveillance for emerging resistance; new antifungals beyond terbinafine (Roemer and Krysan, 2014).
Research Nail Diseases and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Dermatophyte Antifungal Susceptibility with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Nail Diseases and Treatments Research Guide